VRNA

Verona Pharma
VRNA

Overview Fund Activity

88 hedge funds and large institutions have $1.31B invested in Verona Pharma in 2022 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 10 closing their positions.

Holders
88
Holders Change
+20
Holders Change %
+29.41%
% of All Funds
1.42%
Holding in Top 10
16
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+128.57%
% of All Funds
0.26%
New
32
Increased
24
Reduced
25
Closed
10
Calls
$29.8M
Puts
$6.29M
Net Calls
+$23.5M
Net Calls Change
+$19.9M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$56.8M
2
OCA
2
Octagon Capital Advisors
New York
$64.5M
3
Jennison Associates
3
Jennison Associates
New York
$26.9M
4
FLSM
4
Frazier Life Sciences Management
California
$73.6M
5
SSA
5
Schonfeld Strategic Advisors
New York
$11M

Top Sellers

1
O
1
OrbiMed
New York
$119M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$87.4M
3
State Street
3
State Street
Massachusetts
$300K
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$2.14M
5
Citadel Advisors
5
Citadel Advisors
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RCM
1
RA Capital Management
Massachusetts
$165M 6,317,990 +267,990 +4%
NMC
2
NEA Management Company
Maryland
$146M 5,584,753 – –
PA
3
Perceptive Advisors
New York
$128M 4,880,719 -166,545 -3%
O
4
OrbiMed
New York
$119M 4,572,289 -1,122,552 -20%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$87.4M 3,346,370 -830,906 -20%
DTC
6
Deep Track Capital
Connecticut
$83.3M 3,187,415 +358,321 +13%
FFM
7
Fairmount Funds Management
Pennsylvania
$75.1M 2,875,526 +196,544 +7%
FLSM
8
Frazier Life Sciences Management
California
$73.6M 2,815,720 +716,179 +34%
OCA
9
Octagon Capital Advisors
New York
$64.5M 2,468,000 +1,143,132 +86%
A
10
Abingworth
United Kingdom
$64.2M 2,457,500 – –
Fidelity Investments
11
Fidelity Investments
Massachusetts
$56.8M 2,174,146 +1,760,746 +426%
ACM
12
Aisling Capital Management
New York
$34.8M 1,332,485 – –
Jennison Associates
13
Jennison Associates
New York
$26.9M 1,030,627 +1,030,627 New
SB
14
Samsara BioCapital
California
$18.2M 695,001 -243,889 -26%
Janus Henderson Group
15
Janus Henderson Group
United Kingdom
$14.1M 538,634 -61,366 -10%
Two Sigma Investments
16
Two Sigma Investments
New York
$13.7M 524,531 +163,981 +45%
SSA
17
Schonfeld Strategic Advisors
New York
$11M 419,797 +360,797 +612%
PHP
18
Parkman Healthcare Partners
Connecticut
$10.8M 414,448 +91,175 +28%
BlackRock
19
BlackRock
New York
$9.02M 345,325 +345,312 +2,656,246%
Millennium Management
20
Millennium Management
New York
$8.21M 314,053 +234,713 +296%
AAA
21
Affinity Asset Advisors
New York
$8.17M 312,498 -37,502 -11%
IC
22
Ikarian Capital
Texas
$6.67M 255,131 -60,000 -19%
WP
23
Woodline Partners
California
$6.53M 250,000 -125,033 -33%
Point72 Asset Management
24
Point72 Asset Management
Connecticut
$6.32M 241,700 +241,700 New
MAP
25
Moody Aldrich Partners
Massachusetts
$5.78M 221,183 -6,806 -3%
1
2 3 4 5